Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 23rd June 2014
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Better regulation of veterinary medicines needed
pills
A single marketing authorisation is key to boosting innovation in animal health, says IFAH.

IFAH-Europe calls for a single EU marketing authorisation

Better regulation of veterinary medicines is essential for animal health, according to the International Federation for Animal Health (IFAH) Europe.

At its recent conference, the federation called for a truly single market and one EU-wide marketing authorisation process.

The decision-making process on the future of veterinary medicines legislation is due to start later this year.

The federation, which represents manufacturers of veterinary medicines, says it "greatly appreciates" the efforts made so far to improve the efficiency of legislation.

IFAH-Europe wants to see an end to the administrative burden of licensing veterinary medicines to boost innovation in animal health. A pan-European marketing authorisation is key to this goal.

Innovation and investment is being discouraged by this administrative burden alongside insufficient data protection, IFAH claims.

New medicines are essential for fighting animal disease, protecting public health and ensuring safe and sustainable food production.

"A lot of work remains to be done to make veterinary legislation more efficient and to make Europe more attractive for continued investment in innovation," explained IFAH-Europe chairman, Alejandro Bernal.

"We encourage industry and policymakers to work together to build one harmonised licensing system to achieve our ultimate goal of improving the availability of authorised veterinary medicines for the benefit of vets, farmers, pet owners and animals across all EU Member States.

"Now is the time to complete the journey to one true single market in veterinary medicines in the upcoming review of the legislative framework."

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk